Matheus Henrique dos Santos Dias

Loading... 1 0 20 0 false
Credit Name
Dias, Matheus Henrique
Full Name
Matheus Henrique dos Santos Dias
Loading... 2 0 20 0 false
Division
DDC

Research Outputs
(Articles)

Results 1-4 of 4 (Search time: 0.003 seconds).

Fibroblast growth factor 2 lethally sensitizes cancer cells to stress-targeted therapeutic inhibitors  [2019]

Dias, Matheus Henrique ; Fonseca, Cecília Sella ; Zeidler, Julianna Dias ; Costa, Layra Lucy Maria Albuquerque da ; Silva, Marcelo Santos da ; Lopes, Eduardo Cararo ; Reis, Marcelo da Silva ; Noel, Vincent Olivier Jean-Marie ; Santos, Edmilson Ozorio dos ; Prior, Ian A.; Armelin, Hugo Aguirre
Mol Oncol v. 13, n.2, p. 290-306, dez. 2019

Human B cells infected by Trypanosoma cruzi undergo F-actin disruption and cell death via caspase-7 activation and cleavage of phospholipase Cgama1  [2020]

Santos, Marlus Alves dos; Martins, Flávia Alves; Borges, Bruna Cristina; Santos, Júlia de Gouveia; Alves, Rosiane Nascimento; Dias, Matheus Henrique ; Brigido Tavares, Paula Cristina; Brígido, Rebecca Tavares e Silva; Teixeira, Thaise Lara; Rodrigues, Cassiano Costa; Teixeira, Samuel Cota; Costa, Mylla Spirandelli da; Silva, Aline Alves da; Silva, Marcelo José Barbosa; Ávila, Veridiana de Melo Rodrigues; Mineo, Tiago Wilson Patriarca; Souza, Maria Aparecida de; Bahia, Diana; Silva, Cláudio Vieira da
Immunobiology v. 225,n. 3, 151904, jan. 2020

Knockdown of NF-kB1 by shRNA Inhibits the Growth of Renal Cell Carcinoma In Vitro and In Vivo  [2018]

Ikegami, Amanda; Teixeira, Luiz Felipe S.; Braga, Marina S.; Dias, Matheus Henrique ; Lopes, Eduardo Cararo ; Bellini, Maria Helena
Oncol. Res. v. 26. n. 5, p. 743-751, 2018

TCF21/POD-1, a transcritional regulator of SF-1/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors  [2018]

Passaia, Barbara dos Santos; Dias, Matheus Henrique ; Kremer, Jean Lucas; Rauber Antonini, Sonir Roberto; de Almeida, Madson Queiroz; Barisson Villares Fragoso, Maria Candida; Pacicco Lotfi, Claudimara Ferini
Front Endocrinol v. 9, 38, fev. 2018